Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Nasopharyngeal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT06248840
What this trial is testing

Intermittent Oral-esophageal Tube in Delayed Dysphagia After Radiotherapy for Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Zeng Changhao 56
Testing effectiveness (Phase 2)Looking for participantsNCT06851247
What this trial is testing

GAPP Induction and Concurrent Chemoradiotherapy Followed by Toripalimab Maintenance for Nasopharyngeal Carcinoma.

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 47
Testing effectiveness (Phase 2)Study completedNCT00458978
What this trial is testing

Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer

Who this might be right for
Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous Carcinoma+20 more
National Cancer Institute (NCI) 6
Not applicableStudy completedNCT01365208
What this trial is testing

New Approach of Assessing Drug Response for Treatment of Nasopharyngeal Cancer

Who this might be right for
Advanced Nasopharyngeal Carcinoma
Chinese University of Hong Kong 70
Testing effectiveness (Phase 2)Study completedNCT06440187
What this trial is testing

Nivolumab Plus Gemcitabine in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma-HN17-11

Who this might be right for
Recurrent or Metastatic Nasopharyngeal Carcinom
Seoul National University Hospital 38
Testing effectiveness (Phase 2)UnknownNCT01614938
What this trial is testing

Induction Chemotherapy Followed by Concurrent Radiation With Cetuximab or Cisplatin in Locally Advanced Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Carcinoma
Fudan University 46
Early research (Phase 1)Study completedNCT00045006
What this trial is testing

Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Not applicableLooking for participantsNCT06829147
What this trial is testing

A Deep Learning Model for Diagnosing Lymph Node Metastasis in Nasopharyngeal Carcinoma(NPC)

Who this might be right for
Nasopharyngeal Cancinoma (NPC)Lymph Node Metastasis
Sun Yat-sen University 500
Testing effectiveness (Phase 2)Study completedNCT00436293
What this trial is testing

Taxotere + Cisplatin in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
Sanofi 61
Testing effectiveness (Phase 2)Looking for participantsNCT06636734
What this trial is testing

Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial

Who this might be right for
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Human Papillomavirus-Related Neck Squamous Cell Carcinoma of Unknown PrimaryMetastatic Head and Neck Squamous Cell Carcinoma+19 more
Emory University
Large-scale testing (Phase 3)Ended earlyNCT00201344
What this trial is testing

A Phase III Study of Radiotherapy With or Without Adjuvant C/T in Advanced Stage Nasopharyngeal Carcinoma Patients

Who this might be right for
Nasopharyngeal Carcinoma
National Health Research Institutes, Taiwan 320
Not applicableStudy completedNCT01937793
What this trial is testing

Swallowing Exercises for Nasopharyngeal Cancer After Radiation Therapy

Who this might be right for
Nasopharyngeal CancerDysphagia
National Taiwan University Hospital 16
Very early researchUnknownNCT00536952
What this trial is testing

Pilot Study of Pulmozyme (rhDNase) in Patients With Head and Neck Cancers Treated With Radiation Therapy + Chemotherapy

Who this might be right for
Head and Neck Cancer
Northwestern University 36
Testing effectiveness (Phase 2)Ended earlyNCT03769467
What this trial is testing

Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC)

Who this might be right for
Nasopharyngeal CarcinomaNasopharyngeal NeoplasmsEpstein-Barr Virus Infections+2 more
Atara Biotherapeutics 12
Testing effectiveness (Phase 2)Study completedNCT03984357
What this trial is testing

Nivolumab Combined With Chemoradiotherapy Sparing Concurrent Cisplatin in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 152
Not applicableStudy completedNCT00898911
What this trial is testing

Blood Sample Analysis in Predicting Overall Survival in Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
ECOG-ACRIN Cancer Research Group 30
Not applicableStudy completedNCT02586532
What this trial is testing

Evaluation of the Sensitivity of Endoscopy to Detect Nasopharyngeal Carcinoma (NPC) in an Epstein-Barr Virus (EBV)-Based NPC Screening Project in China

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
National Cancer Institute (NCI) 828
Not applicableStudy completedNCT01379872
What this trial is testing

Assessment of New Radiation Oncology Technologies and Treatments

Who this might be right for
Prostate Cancer (Post Prostatectomy)Anal CancerNasopharyngeal Cancer+1 more
Trans Tasman Radiation Oncology Group 138
Testing effectiveness (Phase 2)Study completedNCT01326559
What this trial is testing

Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC)

Who this might be right for
Nasopharyngeal Carcinoma
Hong Kong Nasopharyngeal Cancer Study Group Limited 33
Large-scale testing (Phase 3)Study completedNCT03924986
What this trial is testing

Tislelizumab Combined With Chemotherapy Versus Chemotherapy Alone in Recurrent or Metastatic Nasopharyngeal Cancer (NPC)

Who this might be right for
Recurrent or Metastatic Nasopharyngeal Cancer
BeiGene 263
Next Page
28